Vivus (Nasdaq: VVUS) launched its highly anticipated weight loss drug Qsymia in the U.S. in Sept. By most accounts, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE